Connect Biopharma Holdings Limited
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $-157.1M | $154.8M |
| FY2021 | — | $272.3M | $267.7M |
| FY2022 | — | $158.4M | $78.9M |
| FY2023 | — | $101.5M | $105.7M |
| FY2024 | — | $92.2M | $78.2M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $-157.1M | $154.8M |
| FY2021 | — | $272.3M | $267.7M |
| FY2022 | — | $158.4M | $78.9M |
| FY2023 | — | $101.5M | $105.7M |
| FY2024 | — | $92.2M | $78.2M |